Arkema Shares Drop 3.6% to €62.85, Erasing Previous Day's Gains
The specialty chemicals company erases its previous day's rebound as the market approaches the close on Tuesday, May 12. The share price falls by 3.6% to €62.85, in an SBF 120 down by 1.03% and a CAC 40 losing 0.92%. The stock ranks 113th out of 120 in the broader index, among the top ten declines of the session.
A Significant Decline Bringing the Stock Back to Its Resistance Level
Today's movement brings Arkema back to its resistance threshold identified at €65.20, which it had crossed the previous day at €64.40. However, the stock remains above its 20-day moving average (€61.98), with a narrowed gap of 1.40%. Over longer reference periods, the MM50 at €58.59 and the MM200 at €56.04 remain well below the current price, indicating that the medium-term trend is still oriented upwards despite today's setback.
The RSI at 65 exits the overbought zone it had approached on Monday, after the rebound mentioned in yesterday's brief. The price remains in the upper part of the Bollinger Bands, at 67% of the range. The one-month volatility is limited to 9.78%, without any marked acceleration.
A Clear Financial Calendar Until the End of July
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Following the release of the first quarter 2026 results on May 6, marked by a 14% decline in EBITDA to €283 million and pressured margins, Arkema's calendar offers few immediate catalysts. The general assembly on May 21 has already been covered on May 6. The next financial event is the publication of the first semester 2026 results, scheduled for July 30.
In today's session, the sector context is marked by a rise in Brent crude to $106.46, up 1.80%, amid ongoing tensions around the Strait of Hormuz. Regarding indices, the DAX is down 1.34% and the Dow Jones is losing 0.51% during the session. Over one year, Arkema's stock shows a decline of 5.06%, contained by a beta close to zero (-0.08). The support at €55.70 remains distant from the current price; the €61.98 level, at the MM20, constitutes the nearest technical reference.
Après des mois de janvier et février relativement faibles, la performance du premier trimestre a finalement été légèrement supérieure aux attentes.
Les volumes du Groupe sont stables, et la demande dans les segments clés est en hausse.
Risks mentioned
Impact potentiel de la crise au Moyen-Orient sur la demande mondiale.
Inflation des coûts des intrants résultant de la crise au Moyen-Orient.
Opportunities identified
Développement dans des marchés clés attractifs tels que les batteries et l'impression 3D.
Poursuite des efforts pour gérer strictement les coûts fixes.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
